Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a high burden of comorbidities and anatomical complexity. In this context, the term complex PCI has been introduced over the past decade to identify a broad spectrum of interventions with complex anatomical features, such as severe calcification, chronic total occlusion, bifurcation lesions, or multivessel treatment. 

Resultado a 3 años luego de ATC con técnica de 2- stents vs Provisional stent por bifurcaciones complejasTo date, limited data have been published on the association between complex PCI and the risk of adverse events, and it remains unclear whether complex PCI is independently associated with a higher risk of ischemic and bleeding events.

The aim of this study was to perform a systematic review and a Bayesian meta-analysis to evaluate the association between complex PCI and the risk of ischemic and bleeding events.

The Primary Endpoint (PE) was the rate of myocardial infarction (MI) and major bleeding. Secondary Endpoints (SE) included all-cause mortality, stent thrombosis, cardiovascular death, target vessel or target lesion revascularization, and stroke.

A total of 290,039 patients were included, of whom 33% underwent complex PCI. Compared with non-complex PCI, patients undergoing complex PCI had a higher risk of myocardial infarction (HR 1.71; 95% CI: 1.49–1.96), major bleeding (HR 1.24; 95% CI: 1.14–1.35), all-cause mortality (HR 1.21; 95% CI: 1.12–1.32), cardiovascular death (HR 1.29; 95% CI: 1.15–1.46), stent thrombosis (HR 1.76; 95% CI: 1.49–2.14), target lesion or target vessel revascularization (HR 1.99; 95% CI: 1.58–2.50), and stroke (HR 1.21; 95% CI: 1.03–1.42).

Read also: Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta.

Conclusion: Significant increase in major bleeding and mortality in patients undergoing complex PCI

In conclusion, our systematic review and meta-analysis found that complex PCI is associated with a higher risk of ischemic events, including myocardial infarction, stent thrombosis, and target lesion or target vessel revascularization, compared with non-complex PCI. Additionally, complex PCI was associated with a higher risk of major bleeding. These findings highlight the increased risk associated with complex PCI in terms of both ischemic and bleeding complications.

Original Title: Ischaemic and bleeding events after complex versus non-complex PCI: a systematic review and meta-analysis.

Reference: Raffaele Piccolo et al. EuroIntervention 2026;22:e402-e414.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAFE-PROTECT at 12 Months: AnchorMan vs. Watchman for Left Atrial Appendage Closure

Percutaneous left atrial appendage (LAA) closure is an alternative therapeutic strategy for reducing the risk of stroke in patients with atrial fibrillation (AF). Randomized...

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...